Mitochondrial DAMPs and altered mitochondrial dynamics in OxLDL burden in atherosclerosis

Bisma Khwaja1, Finosh G Thankam1, Devendra K Agrawal2

  • 1Department of Translational Research, Western University of Health Sciences, Pomona, CA, 91766, USA.

Insights

Mitochondrial damage-associated molecular patterns (mtDAMPs) and oxidized LDL (oxLDL) trigger sterile inflammation in atherosclerosis by activating the NLRP3 inflammasome. This pathway promotes inflammatory cytokines, driving plaque formation and cardiovascular disease.

Area of Science:

  • Cardiovascular Pathology
  • Immunology
  • Molecular Biology

Background:

  • Atherosclerosis leads to severe cardiovascular diseases, with oxidized low-density lipoprotein (oxLDL) accumulation being a key factor.
  • Emerging research highlights mitochondrial damage-associated molecular patterns (mtDAMPs) as critical initiators of sterile inflammation in atherosclerosis, acting alongside oxLDL.

Purpose of the Study:

  • To critically review and discuss the central role of the NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome in mtDAMP-induced sterile inflammation in atherosclerosis.
  • To explore the involvement of specific components like caspase-1, pregnane X receptor (PXR), adenosine monophosphate activated protein kinase (AMPK), protein phosphatase 2A (PP2A), and thioredoxin-interacting protein (TXNIP).
  • To examine the role of downstream cytokines, including interleukin-1β (IL-1β) and IL-18, as potential mediators of atherosclerosis.

Main Methods:

  • Literature review and critical discussion of existing research on mtDAMPs, oxLDL, and the NLRP3 inflammasome in atherosclerosis.
  • Analysis of signaling pathways involved in mtDAMP-mediated inflammation.
  • Identification of key molecular components and downstream cytokines implicated in the atherosclerotic process.

Main Results:

  • mtDAMPs, including mitochondrial DNA (mtDNA) and other components, are implicated in proatherogenic roles.
  • mtDAMPs activate the NLRP3 inflammasome, leading to the secretion of pro-inflammatory cytokines like IL-1β.
  • This inflammatory cascade contributes to vascular smooth muscle and fibroblast proliferation, arterial wall thickening, and plaque formation.

Conclusions:

  • The NLRP3 inflammasome plays a central role in mtDAMP-induced sterile inflammation in atherosclerosis.
  • Understanding the interplay between mtDAMPs and oxLDL offers significant potential for developing novel therapeutic strategies against atherosclerosis.
  • Targeting the NLRP3 inflammasome pathway presents a promising avenue for novel therapeutic interventions in atherosclerosis.

Related Concept Videos

Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
15.1K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
366
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
185
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
114
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
17.8K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
669